Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Alkeus Pharmaceuticals has raised $150.0M in total funding. The most recent round was Series B. The last funding was announced in June 2023.
Alkeus Pharmaceuticals's investors include Wellington Management, MassChallenge, Sofinnova Investments, Bain Capital Life Sciences, TCG Crossover.
Alkeus Pharmaceuticals is headquartered in Cambridge, United States.
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Alkeus Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alkeus Pharmaceuticals — Funding & Investors." VCBacked, June 5, 2023, https://www.vcbacked.co/company/alkeus-pharmaceuticals. Accessed July 19, 2026.
VCBacked. (2023). Alkeus Pharmaceuticals — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/alkeus-pharmaceuticals
{{cite web |title=Alkeus Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/alkeus-pharmaceuticals |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated